389 related articles for article (PubMed ID: 34345916)
41. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
Heiss WD; Szelies B; Kessler J; Herholz K
Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
[TBL] [Abstract][Full Text] [Related]
42. Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention.
Ding F; Yao J; Rettberg JR; Chen S; Brinton RD
PLoS One; 2013; 8(11):e79977. PubMed ID: 24244584
[TBL] [Abstract][Full Text] [Related]
43. Risk factors for Alzheimer's disease during aging. Impacts of glucose/energy metabolism.
Hoyer S
J Neural Transm Suppl; 1998; 54():187-94. PubMed ID: 9850927
[TBL] [Abstract][Full Text] [Related]
44. Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death.
Elstner M; Morris CM; Heim K; Bender A; Mehta D; Jaros E; Klopstock T; Meitinger T; Turnbull DM; Prokisch H
Acta Neuropathol; 2011 Jul; 122(1):75-86. PubMed ID: 21541762
[TBL] [Abstract][Full Text] [Related]
45. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
Belaidi AA; Bush AI
J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
[TBL] [Abstract][Full Text] [Related]
46. Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease.
Zhao L; Mao Z; Woody SK; Brinton RD
Neurobiol Aging; 2016 Jun; 42():69-79. PubMed ID: 27143423
[TBL] [Abstract][Full Text] [Related]
47. Lipid and Lipid Raft Alteration in Aging and Neurodegenerative Diseases: A Window for the Development of New Biomarkers.
Mesa-Herrera F; Taoro-González L; Valdés-Baizabal C; Diaz M; Marín R
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382686
[TBL] [Abstract][Full Text] [Related]
48. Energy metabolism, oxidative stress and neuronal degeneration in Alzheimer's disease.
Sims NR
Neurodegeneration; 1996 Dec; 5(4):435-40. PubMed ID: 9117559
[TBL] [Abstract][Full Text] [Related]
49. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
50. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
[TBL] [Abstract][Full Text] [Related]
51. Astrocytic Pathological Calcium Homeostasis and Impaired Vesicle Trafficking in Neurodegeneration.
Vardjan N; Verkhratsky A; Zorec R
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208745
[TBL] [Abstract][Full Text] [Related]
52. [Role of oxidative RNA damage in aging and neurodegenerative disorders].
Nunomura A
Brain Nerve; 2013 Feb; 65(2):179-94. PubMed ID: 23399675
[TBL] [Abstract][Full Text] [Related]
53. Brain energy metabolism in Alzheimer's disease: 99mTc-HMPAO SPECT imaging during verbal fluency and role of astrocytes in the cellular mechanism of 99mTc-HMPAO retention.
Slosman DO; Ludwig C; Zerarka S; Pellerin L; Chicherio C; de Ribaupierre A; Annoni JM; Bouras C; Herrmann F; Michel JP; Giacobini E; Magistretti PJ
Brain Res Brain Res Rev; 2001 Oct; 36(2-3):230-40. PubMed ID: 11690620
[TBL] [Abstract][Full Text] [Related]
54. Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders.
Jęśko H; Wencel P; Strosznajder RP; Strosznajder JB
Neurochem Res; 2017 Mar; 42(3):876-890. PubMed ID: 27882448
[TBL] [Abstract][Full Text] [Related]
55. Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases.
Jensen NJ; Wodschow HZ; Nilsson M; Rungby J
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233502
[TBL] [Abstract][Full Text] [Related]
56. Sphingolipids in neurodegeneration.
Haughey NJ
Neuromolecular Med; 2010 Dec; 12(4):301-5. PubMed ID: 20737248
[TBL] [Abstract][Full Text] [Related]
57. Lipid integration in neurodegeneration: an overview of Alzheimer's disease.
Yadav RS; Tiwari NK
Mol Neurobiol; 2014 Aug; 50(1):168-76. PubMed ID: 24590317
[TBL] [Abstract][Full Text] [Related]
58. Global Metabolic Shifts in Age and Alzheimer's Disease Mouse Brains Pivot at NAD+/NADH Redox Sites.
Dong Y; Brewer GJ
J Alzheimers Dis; 2019; 71(1):119-140. PubMed ID: 31356210
[TBL] [Abstract][Full Text] [Related]
59. Nucleus-cytoplasm cross-talk in the aging brain.
Benvegnù S
J Neurosci Res; 2020 Feb; 98(2):247-261. PubMed ID: 31131478
[TBL] [Abstract][Full Text] [Related]
60. Existing data suggest that Alzheimer's disease is preventable.
Mattson MP
Ann N Y Acad Sci; 2000; 924():153-9. PubMed ID: 11193791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
